Skip to main content

Table 2 Pharmacists' Inquiries and Recommendations in Response to the Simulated Clinical Scenarios

From: Non prescribed sale of antibiotics in Riyadh, Saudi Arabia: A Cross Sectional Study

Simulated clinical scenario Recommended medical evaluation (%)
(95% CI)
Asked about associated symptoms
(%)
(95% CI)
Asked about presence of fever
(%)
(95% CI)
Asked about pregnancy status
(%)
(95% CI)
Dispensed antibiotic
Sore throat
(n = 58)
5%
(1.1%-14.4%)
40%
(27.0% -53.4%)
9%
(2.9%-19.0%)
NA Amoxicillin/Clavulanate (60%)
Azithromycin (20%)
Amoxicillin (17%)
Others (3%)
Acute bronchitis
(n = 44)
14%
(5.2%-27.4%)
43%
(28.3%-59.0%)
25%
(13.2%-40.3%)
NA Amoxicillin/Clavulanate (42%)
Amoxicillin (27%)
Azithromycin (15%)
Others (16%)
UTI
(n = 58)
10%
(3.9%-21.2%)
22%
(12.5%-35.3%)
14%
(6.1%-25.4%)
23%
(12.5%-35.3%)
Ciprofloxacin (86%)
Amoxicillin (7%)
Cefixime (2%)
Clarithromycin (2%)
Others (3%)
Diarrhea
(n = 59)
3%
(0.4%-11.7%)
62%
(49.1%-75.0%)
14%
(6.0%-23.0%)
NA Metronidazole (89%)
Ciprofloxacin (5%)
Cotrimoxazole (2%)
Ofloxacin (2%)
Others (2%)
Acute sinusitis
(n = 55)
2%
(0.0-9.7%)
73%
(59.0%-83.9)
9%
(3.0%-20.0%)
NA Amoxicillin/Clavulanate (58%)
Azithromycin (26%)
Amoxicillin (8%)
Cefaclor (3%)
Ofloxacillin (3%)
Others (2%)
Otitis media
(n = 53)
47%
(33.3% -61.4%)
19%
(8.3%-29.4%)
2%
(0.0-10.1)
NA Amoxicillin/Clavulanate (44%)
Amoxicillin (29%)
Cephalexin (15%)
Azithromycin (4%) Cefaclor (4%)
Cefixime (4%)
  1. NA: Not applicable CI: Confidence interval